...
首页> 外文期刊>International journal of oncology >Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
【24h】

Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness

机译:具有多重耐药性和增强侵袭性的吉西他滨耐药的人胆管癌细胞系的建立和表征

获取原文

摘要

To establish and characterize the gemcitabine-resistant cholangiocarcinoma (CCA) cell lines, CCA KKU?M139 and KKU?M214 cell lines were exposed stepwisely to increasing gemcitabine (GEM). The resultant drug-resistant cell lines, KKU?M139/GEM and KKU?M214/GEM, retained the resistant phenotype in drug-free medium at least for 2 months. Sulforhodamine B assay demonstrated that KKU?M139/GEM and KKU?M214/GEM were 25.88- and 62.31-fold more resistant to gemcitabine than their parental cells. Both gemcitabine-resistant cell lines were cross-resistant to 5-fluorouracil (5-FU), doxorubicin and paclitaxel indicating their multidrug-resistant nature. Using reverse transcriptase-polymerase chain reaction (RT-PCR), real-time PCR and western blot analyses, gemcitabine-resistant cells showed upregulation of RRM1 and downregulation of hENT1 and dCK. In relation to multidrug resistance, these cell lines showed upregulation of multidrug resistance protein 1 (MRP1) leading to an increase of drug efflux. Using cell adhesion and Boyden chamber transwell assays, these cell lines also showed higher cell adhesion, migration and invasion capabilities via the activations of protein kinase C (PKC), focal adhesion kinase (FAK), extracellular signal-regulated kinase-1/2 (ERK1/2) and nuclear factor-κB (NF-κB). Higher activity of matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (uPA) was also observed by a gelatin zymography assay and a casein-plasminogen zymography assay. Flow cytometry analysis indicated the G2/M arrest regulated by downregulation of cyclin?B1 and cyclin-dependent kinase?1 (Cdk1) resulted in an extended population doubling time. Using Annexin?V/propidium iodide staining, evasion of apoptosis via an intrinsic pathway was observed in both cell lines in association with upregulation of Bcl-2 and downregulation of Bax. Interestingly, Fas was additionally downregulated in KKU?M214/GEM supporting the view of its higher GEM resistant characteristics. These findings indicate that long-term exposure of CCA cell lines to gemcitabine induce not only multidrug resistance but also enhance their invasiveness.
机译:为了建立和鉴定吉西他滨耐药性胆管癌(CCA)细胞系,将CCA KKU?M139和KKU?M214细胞系逐步暴露于不断增加的吉西他滨(GEM)中。所得的耐药细胞株KKU?M139 / GEM和KKU?M214 / GEM在无药培养基中至少保留了2个月的耐药表型。 Sulforhodamine B分析表明,KKU?M139 / GEM和KKU?M214 / GEM对吉西他滨的耐药性比其亲本细胞高25.88-和62.31-倍。两种吉西他滨耐药细胞系均对5-氟尿嘧啶(5-FU),阿霉素和紫杉醇具有交叉耐药性,表明它们具有多重耐药性。使用逆转录聚合酶链反应(RT-PCR),实时PCR和Western印迹分析,吉西他滨耐药细胞显示RRM1上调,hENT1和dCK下调。关于多药耐药性,这些细胞系显示出多药耐药蛋白1(MRP1)的上调,导致药物外排增加。通过细胞粘附和Boyden室转运分析,这些细胞系还通过激活蛋白激酶C(PKC),粘着斑激酶(FAK),细胞外信号调节激酶-1/2( ERK1 / 2)和核因子-κB(NF-κB)。通过明胶酶谱测定法和酪蛋白-纤溶酶原酶测定法也观察到基质金属蛋白酶9(MMP-9)和尿激酶纤溶酶原激活剂(uPA)的活性更高。流式细胞仪分析表明,细胞周期蛋白β1和细胞周期蛋白依赖性激酶β1(Cdk1)的下调调节了G2 / M的阻滞,导致群体倍增时间延长。使用膜联蛋白ΔV/碘化丙锭染色,在两种细胞系中均观察到通过内在途径的细胞凋亡的逃逸与Bcl-2的上调和Bax的下调相关。有趣的是,Fas在KKU?M214 / GEM中另外被下调,以支持其具有更高的GEM抗性的观点。这些发现表明,CCA细胞系长期暴露于吉西他滨不仅会引起多药耐药性,还会增强其侵袭性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号